Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


A major upgrade for independent medical research in NZ

A major upgrade for independent medical research in New Zealand

Wellington’s Malaghan Institute of Medical Research has announced a $28 million boost for cancer, asthma and inflammatory disease research in New Zealand.

Cancer and asthma are some of New Zealand’s most devastating diseases. The Malaghan Institute has been recognised as a key independent organisation to meet this challenge through the recent granting of $28 million by the Health Research Council of New Zealand (HRC). The funding, which will be provided over the next seven years, secures a solid future for the improvement in health for all New Zealanders.

The Malaghan Institute’s Director Professor Graham Le Gros says: “We are humbled by the responsibility and trust placed with us. People of all ages in New Zealand are suffering and we need to find better, cheaper more effective ways to treat them.

“This HRC funding establishes the Malaghan Institute as New Zealands premier independent medical research centre for not only finding better treatments for diseases like cancer and asthma, but also many others that have an immunological, infectious or inflammatory basis. This investment by the Government’s HRC will secure the capability we have developed for the benefit of New Zealand while still allowing us to retain the independent spirit and culture and the philanthropic support that has been the source of our discoveries”

The HRC extensively reviewed the core research programmes headed by Professor’s Franca Ronchese, Ian Hermans, Graham Le Gros and Mike Berridge and gave them the stamp of approval as the most likely to produce breakthrough results in the future.

“This funding gives us the wherewithal to translate the many recent exciting discoveries into practical solutions for patients. The new funding also becomes the platform for our up and coming investigators like Dr Elizabeth Forbes-Blom and Dr Robert Weinkov whose youth and vigour will push us to think more boldly.”

Professor Le Gros says: “When combined with philanthropic support from the community, the Malaghan Institute now has the capability to become one of New Zealands enduring and productive assets for a better future.

"It's really exciting. Our understanding of how to use our immune system to treat diseases like cancer has been transformed over the last few years and this funding will place us at the heart of future advances in other disease areas. We will be able to support and build new collaborations throughout New Zealand and across the world to ensure we produce the cutting edge research discoveries New Zealanders need."

The Institute has been operating for over 40 years in Wellington and brings together over 70 medical researchers from across a wide range of fields, including immunologists, cell biologists and bioinformatic specialists. It is New Zealand’s largest and oldest independent biomedical research organisation.

“As an independent organisation the Malaghan Institute relies on continuing philanthropic support to carry out its work. This new funding provides a secure platform for all our donors and supporters ensuring that their generous gifts are now underpinned by credible capability through the HRC grants.”

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Post-Post: Brian Roche To Step Down As NZ Post CEO

Brian Roche will step down as chief executive of New Zealand Post in April 2017, having led the state-owned postal service's drive to adjust to shrinking mail volumes with a combination of cost cuts, asset sales, modernisation and expansion of new businesses. More>>

ALSO:

Company Results: Air NZ Rides The Tourism Boom With Record Full-Year Earnings

Air New Zealand has ridden the tourism boom and staved off increased competition to deliver the best full-year earnings in its 76-year history. More>>

ALSO:

New PGP: Sheep Milk Industry Gets $12.6M Crown Funding

The Sheep - Horizon Three programme aims to develop "a market driven, end-to-end value chain generating annual revenues of between $200 million and $700 million by 2030," according to a joint statement. More>>

ALSO:

Half Full: Fonterra Raises Forecast Milk Price

Fonterra Co-operative Group Limited today increased its 2016/17 forecast Farmgate Milk Price by 50 cents to $4.75 per kgMS. When combined with the forecast earnings per share range for the 2017 financial year of 50 to 60 cents, the total payout available to farmers in the current season is forecast to be $5.25 to $5.35 before retentions. More>>

ALSO:

Keep Digging: Seabed Ironsands Miner TransTasman Tries Again

The first company to attempt to gain a resource consent to mine ironsands from the ocean floor in New Zealand's Exclusive Economic Zone has lodged a new application containing fresh scientific and other evidence it hopes will persuade regulators after their initial application was turned down in 2014. More>>

Wool Pulled: Duvets Sold As ‘Premium Alpaca’ Mostly Sheep’s Wool

Rotorua business Budge Collection Limited (Budge) and sole director, Sun Dong Kim, were convicted and fined a total of $71,250 in Auckland District Court after each pleading guilty to four charges of misrepresenting how much alpaca fibre was in their duvets. More>>

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news